These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 1286161

  • 21. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs.
    Potter AJ, Rabinovitch PS.
    Mutat Res; 2005 May 02; 572(1-2):27-44. PubMed ID: 15790488
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Development of cell cycle active drugs for the treatment of gastrointestinal cancers: a new approach to cancer therapy.
    Schwartz GK.
    J Clin Oncol; 2005 Jul 10; 23(20):4499-508. PubMed ID: 16002840
    [Abstract] [Full Text] [Related]

  • 25. Double blockade of cell cycle at g(1)-s transition and m phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand.
    Jiang JD, Denner L, Ling YH, Li JN, Davis A, Wang Y, Li Y, Roboz J, Wang LG, Perez-Soler R, Marcelli M, Bekesi G, Holland JF.
    Cancer Res; 2002 Nov 01; 62(21):6080-8. PubMed ID: 12414632
    [Abstract] [Full Text] [Related]

  • 26. Cell cycle checkpoints, genetic instability and cancer.
    Weinert T, Lydall D.
    Semin Cancer Biol; 1993 Apr 01; 4(2):129-40. PubMed ID: 8513148
    [Abstract] [Full Text] [Related]

  • 27. Chromosome segregation and cancer: cutting through the mystery.
    Jallepalli PV, Lengauer C.
    Nat Rev Cancer; 2001 Nov 01; 1(2):109-17. PubMed ID: 11905802
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Anticancer chemotherapy. I. Chemicals and action mechanisms].
    Amiel JL.
    Nouv Presse Med; 1979 Apr 28; 8(19):1567-9. PubMed ID: 492974
    [No Abstract] [Full Text] [Related]

  • 34. Modulation of cellular response to anticancer treatment by caffeine: inhibition of cell cycle checkpoints, DNA repair and more.
    Sabisz M, Skladanowski A.
    Curr Pharm Biotechnol; 2008 Aug 28; 9(4):325-36. PubMed ID: 18691092
    [Abstract] [Full Text] [Related]

  • 35. Achieving Precision Death with Cell-Cycle Inhibitors that Target DNA Replication and Repair.
    Lin AB, McNeely SC, Beckmann RP.
    Clin Cancer Res; 2017 Jul 01; 23(13):3232-3240. PubMed ID: 28331049
    [Abstract] [Full Text] [Related]

  • 36. Selective Autophagy Regulates Cell Cycle in Cancer Therapy.
    Zheng K, He Z, Kitazato K, Wang Y.
    Theranostics; 2019 Jul 01; 9(1):104-125. PubMed ID: 30662557
    [Abstract] [Full Text] [Related]

  • 37. Cell cycle checkpoints as therapeutic targets.
    Stewart ZA, Pietenpol JA.
    J Mammary Gland Biol Neoplasia; 1999 Oct 01; 4(4):389-400. PubMed ID: 10705922
    [Abstract] [Full Text] [Related]

  • 38. Cancer chemotherapy. The relevance of certain concepts of cell cycle kinetics.
    Hill BT.
    Biochim Biophys Acta; 1978 Dec 11; 516(4):389-417. PubMed ID: 361085
    [No Abstract] [Full Text] [Related]

  • 39. Cell cycle specificity of anticancer agents.
    van Putten LM.
    Antibiot Chemother (1971); 1978 Dec 11; 23():128-34. PubMed ID: 348073
    [No Abstract] [Full Text] [Related]

  • 40. Mathematical analysis of cancer chemotherapy: the effects of chemotherapeutic agents on the cell cycle traverse.
    Chuang SN, Soong TT.
    Bull Math Biol; 1978 Dec 11; 40(4):499-512. PubMed ID: 678695
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.